Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juhan Kim

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Neurotoxicology|August 4, 2004
Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cellsSeong-Ho Koh, Seung H Kim, Hyugsung Kwon, et al.
European Neurology|January 25, 2006
The role of matrix metalloproteinase 9 in early neurological worsening of acute lacunar infarctionYoung Seo Kim, Kyu-Yong Lee, Seong-Ho Koh, et al.
The European Journal of Neuroscience|September 10, 2004
The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signalsSeong-Ho Koh, Younjoo Park, Chi Won Song, et al.
Toxicology|September 1, 2004
Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signalsSeong-Ho Koh, Hyugsung Kwon, Kyung Suk Kim, et al.
Korean Circulation Journal|July 27, 2019
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryDong Ho Shin, Hyun Jae Kang, Jae Sik Jang, et al.
Clinical Biochemistry|July 1, 2009
Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposusSeungcheol Lee, Chan Sam Moon, Donggeun Sul, et al.
Clinical Hypertension|May 12, 2020
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?Sungha Park, Hae Young Lee, Eun Joo Cho, et al.
Neuroscience Letters|December 17, 2005
The effect of epigallocatechin gallate on suppressing disease progression of ALS model miceSeong-Ho Koh, Sang Mok Lee, Hyun Young Kim, et al.
Korean Circulation Journal|June 2, 2017
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryJae-Sik Jang, Kyoo-Rok Han, Keon-Woong Moon, et al.
Korean Circulation Journal|August 3, 2017
Erratum: The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryHyeon-Cheol Gwon, Dong Woon Jeon, Hyun-Jae Kang, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Neurotoxicology|August 4, 2004
Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cellsSeong-Ho Koh, Seung H Kim, Hyugsung Kwon, et al.
European Neurology|January 25, 2006
The role of matrix metalloproteinase 9 in early neurological worsening of acute lacunar infarctionYoung Seo Kim, Kyu-Yong Lee, Seong-Ho Koh, et al.
The European Journal of Neuroscience|September 10, 2004
The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signalsSeong-Ho Koh, Younjoo Park, Chi Won Song, et al.
Toxicology|September 1, 2004
Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signalsSeong-Ho Koh, Hyugsung Kwon, Kyung Suk Kim, et al.
Korean Circulation Journal|July 27, 2019
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryDong Ho Shin, Hyun Jae Kang, Jae Sik Jang, et al.
Clinical Biochemistry|July 1, 2009
Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposusSeungcheol Lee, Chan Sam Moon, Donggeun Sul, et al.
Clinical Hypertension|May 12, 2020
Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?Sungha Park, Hae Young Lee, Eun Joo Cho, et al.
Neuroscience Letters|December 17, 2005
The effect of epigallocatechin gallate on suppressing disease progression of ALS model miceSeong-Ho Koh, Sang Mok Lee, Hyun Young Kim, et al.
Korean Circulation Journal|June 2, 2017
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryJae-Sik Jang, Kyoo-Rok Han, Keon-Woong Moon, et al.
Korean Circulation Journal|August 3, 2017
Erratum: The Practice Pattern of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryHyeon-Cheol Gwon, Dong Woon Jeon, Hyun-Jae Kang, et al.
Pageof 7